Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 97

1.

Patterns and dynamics of canopy-root coupling in tropical tree saplings vary with light intensity but not with root depth.

Oren I, Mannerheim N, Dumbur R, Fangmeier A, Buchmann N, Grünzweig JM.

New Phytol. 2019 Aug 30. doi: 10.1111/nph.16153. [Epub ahead of print]

PMID:
31469437
2.

Reply to Nucci.

Bitterman R, Hardak E, Guralnik L, Paul M, Oren I.

Clin Infect Dis. 2019 May 10. pii: ciz382. doi: 10.1093/cid/ciz382. [Epub ahead of print] No abstract available.

PMID:
31075162
3.

Diagnostic role of polymerase chain reaction in bronchoalveolar lavage fluid for invasive pulmonary aspergillosis in immunocompromised patients - A retrospective cohort study.

Hardak E, Fuchs E, Leskes H, Geffen Y, Zuckerman T, Oren I.

Int J Infect Dis. 2019 Jun;83:20-25. doi: 10.1016/j.ijid.2019.03.025. Epub 2019 Mar 26.

4.

Baseline Chest Computed Tomography for Early Diagnosis of Invasive Pulmonary Aspergillosis in Hemato-oncological Patients: A Prospective Cohort Study.

Bitterman R, Hardak E, Raines M, Stern A, Zuckerman T, Ofran Y, Lavi N, Guralnik L, Frisch A, Nudelman O, Paul M, Oren I.

Clin Infect Dis. 2019 Oct 30;69(10):1805-1808. doi: 10.1093/cid/ciz194.

PMID:
30855077
5.

Effect and Safety of Meropenem-Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections: The TANGO II Randomized Clinical Trial.

Wunderink RG, Giamarellos-Bourboulis EJ, Rahav G, Mathers AJ, Bassetti M, Vazquez J, Cornely OA, Solomkin J, Bhowmick T, Bishara J, Daikos GL, Felton T, Furst MJL, Kwak EJ, Menichetti F, Oren I, Alexander EL, Griffith D, Lomovskaya O, Loutit J, Zhang S, Dudley MN, Kaye KS.

Infect Dis Ther. 2018 Dec;7(4):439-455. doi: 10.1007/s40121-018-0214-1. Epub 2018 Oct 1.

6.

Severe cytomegalovirus enterocolitis developing following daratumumab exposure in three patients with multiple myeloma.

Lavi N, Okasha D, Sabo E, Oren I, Benyamini N, Bar-Yoseph H.

Eur J Haematol. 2018 Aug 18. doi: 10.1111/ejh.13164. [Epub ahead of print]

PMID:
30120798
7.

Circadian and Brain State Modulation of Network Hyperexcitability in Alzheimer's Disease.

Brown R, Lam AD, Gonzalez-Sulser A, Ying A, Jones M, Chou RC, Tzioras M, Jordan CY, Jedrasiak-Cape I, Hemonnot AL, Abou Jaoude M, Cole AJ, Cash SS, Saito T, Saido T, Ribchester RR, Hashemi K, Oren I.

eNeuro. 2018 May 17;5(2). pii: ENEURO.0426-17.2018. doi: 10.1523/ENEURO.0426-17.2018. eCollection 2018 Mar-Apr.

8.

Isavuconazole for treatment of rare invasive fungal diseases.

Cornely OA, Mullane KM, Ostrosky-Zeichner L, Maher RM, Croos-Dabrera R, Lu Q, Lademacher C, Perfect JR, Oren I, Schmitt-Hoffmann AH, Giladi M, Marty FM, Rahav G.

Mycoses. 2018 Aug;61(8):518-533. doi: 10.1111/myc.12778.

PMID:
29611246
9.

Isavuconazole for treatment of invasive fungal diseases caused by more than one fungal species.

Marty FM, Cornely OA, Mullane KM, Ostrosky-Zeichner L, Maher RM, Croos-Dabrera R, Lu Q, Lademacher C, Oren I, Schmitt-Hoffmann AH, Giladi M, Rahav G, Perfect JR.

Mycoses. 2018 Jul;61(7):485-497. doi: 10.1111/myc.12777. Epub 2018 Apr 26.

PMID:
29611227
10.

Community-acquired respiratory infections are common in patients with non-Hodgkin lymphoma and multiple myeloma.

Lavi N, Avivi I, Kra-Oz Z, Oren I, Hardak E.

Support Care Cancer. 2018 Jul;26(7):2425-2431. doi: 10.1007/s00520-018-4079-3. Epub 2018 Feb 9.

PMID:
29427192
11.

[REDUCTION OF ANTIBIOTIC CONSUMPTION IN RAMBAM HEALTH CARE CAMPUS - THE ROLE OF AN ANTIBIOTIC STEWARDSHIP PROGRAM].

Bitterman R, Raz-Pasteur A, Azzam ZS, Karban A, Levy Y, Hayek T, Braun E, Oren I, Bar-Lavi Y, Kassis I, Hussein K, Paul M.

Harefuah. 2017 Sep;156(9):573-577. Hebrew.

PMID:
28971655
12.

Does molecular analysis increase the efficacy of bronchoalveolar lavage in the diagnosis and management of respiratory infections in hemato-oncological patients?

Oren I, Hardak E, Zuckerman T, Geffen Y, Hoffman R, Yigla M, Avivi I.

Int J Infect Dis. 2016 Sep;50:48-53. doi: 10.1016/j.ijid.2016.07.011. Epub 2016 Jul 30.

13.

Campylobacter bacteraemia: 16 years of experience in a single centre.

Hussein K, Raz-Pasteur A, Shachor-Meyouhas Y, Geffen Y, Oren I, Paul M, Kassis I.

Infect Dis (Lond). 2016 Nov-Dec;48(11-12):796-9. doi: 10.1080/23744235.2016.1195916. Epub 2016 Jun 20.

PMID:
27320494
14.

Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis.

Marty FM, Ostrosky-Zeichner L, Cornely OA, Mullane KM, Perfect JR, Thompson GR 3rd, Alangaden GJ, Brown JM, Fredricks DN, Heinz WJ, Herbrecht R, Klimko N, Klyasova G, Maertens JA, Melinkeri SR, Oren I, Pappas PG, Ráčil Z, Rahav G, Santos R, Schwartz S, Vehreschild JJ, Young JH, Chetchotisakd P, Jaruratanasirikul S, Kanj SS, Engelhardt M, Kaufhold A, Ito M, Lee M, Sasse C, Maher RM, Zeiher B, Vehreschild MJGT; VITAL and FungiScope Mucormycosis Investigators.

Lancet Infect Dis. 2016 Jul;16(7):828-837. doi: 10.1016/S1473-3099(16)00071-2. Epub 2016 Mar 9.

PMID:
26969258
15.

Polymicrobial pulmonary infection in patients with hematological malignancies: prevalence, co-pathogens, course and outcome.

Hardak E, Avivi I, Berkun L, Raz-Pasteur A, Lavi N, Geffen Y, Yigla M, Oren I.

Infection. 2016 Aug;44(4):491-7. doi: 10.1007/s15010-016-0873-3. Epub 2016 Jan 20.

PMID:
26792011
16.

Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial.

Maertens JA, Raad II, Marr KA, Patterson TF, Kontoyiannis DP, Cornely OA, Bow EJ, Rahav G, Neofytos D, Aoun M, Baddley JW, Giladi M, Heinz WJ, Herbrecht R, Hope W, Karthaus M, Lee DG, Lortholary O, Morrison VA, Oren I, Selleslag D, Shoham S, Thompson GR 3rd, Lee M, Maher RM, Schmitt-Hoffmann AH, Zeiher B, Ullmann AJ.

Lancet. 2016 Feb 20;387(10020):760-9. doi: 10.1016/S0140-6736(15)01159-9. Epub 2015 Dec 10.

PMID:
26684607
17.

Mortality burden related to infection with carbapenem-resistant Gram-negative bacteria among haematological cancer patients: a retrospective cohort study.

Andria N, Henig O, Kotler O, Domchenko A, Oren I, Zuckerman T, Ofran Y, Fraser D, Paul M.

J Antimicrob Chemother. 2015 Nov;70(11):3146-53. doi: 10.1093/jac/dkv218. Epub 2015 Jul 24.

PMID:
26209312
18.

JC polyomavirus reactivation is common following allogeneic stem cell transplantation and its preemptive detection may prevent lethal complications.

Wittmann T, Horowitz N, Benyamini N, Henig I, Zuckerman T, Rowe JM, Kra-Oz Z, Szwarcwort Cohen M, Oren I, Avivi I.

Bone Marrow Transplant. 2015 Jul;50(7):984-91. doi: 10.1038/bmt.2015.68. Epub 2015 Apr 13.

PMID:
25867649
19.

Early impact of PCV7/PCV13 sequential introduction to the national pediatric immunization plan, on adult invasive pneumococcal disease: A nationwide surveillance study.

Regev-Yochay G, Paran Y, Bishara J, Oren I, Chowers M, Tziba Y, Istomin V, Weinberger M, Miron D, Temper V, Rahav G, Dagan R; IAIPD group.

Vaccine. 2015 Feb 25;33(9):1135-42. doi: 10.1016/j.vaccine.2015.01.030. Epub 2015 Jan 20.

PMID:
25613717
20.

Genome-wide distribution of Auts2 binding localizes with active neurodevelopmental genes.

Oksenberg N, Haliburton GD, Eckalbar WL, Oren I, Nishizaki S, Murphy K, Pollard KS, Birnbaum RY, Ahituv N.

Transl Psychiatry. 2014 Sep 2;4:e431. doi: 10.1038/tp.2014.78.

21.

Up to date epidemiology, diagnosis and management of invasive fungal infections.

Oren I, Paul M.

Clin Microbiol Infect. 2014 Jun;20 Suppl 6:1-4. doi: 10.1111/1469-0691.12642. No abstract available.

22.

Association between viral load of varicella zoster virus in cerebrospinal fluid and the clinical course of central nervous system infection.

Rottenstreich A, Oz ZK, Oren I.

Diagn Microbiol Infect Dis. 2014 Jun;79(2):174-7. doi: 10.1016/j.diagmicrobio.2014.02.015. Epub 2014 Mar 1.

PMID:
24666705
23.

Spectral statistics of permutation matrices.

Oren I, Smilansky U.

Philos Trans A Math Phys Eng Sci. 2013 Dec 16;372(2007):20120508. doi: 10.1098/rsta.2012.0508. Print 2014 Jan 28.

24.

Eradication of carbapenem-resistant Enterobacteriaceae gastrointestinal colonization with nonabsorbable oral antibiotic treatment: A prospective controlled trial.

Oren I, Sprecher H, Finkelstein R, Hadad S, Neuberger A, Hussein K, Raz-Pasteur A, Lavi N, Saad E, Henig I, Horowitz N, Avivi I, Benyamini N, Fineman R, Ofran Y, Haddad N, Rowe JM, Zuckerman T.

Am J Infect Control. 2013 Dec;41(12):1167-72. doi: 10.1016/j.ajic.2013.04.018.

PMID:
24274912
25.

Feedforward inhibition underlies the propagation of cholinergically induced gamma oscillations from hippocampal CA3 to CA1.

Zemankovics R, Veres JM, Oren I, Hájos N.

J Neurosci. 2013 Jul 24;33(30):12337-51. doi: 10.1523/JNEUROSCI.3680-12.2013.

26.

Group G streptococcal endocarditis-associated hemophagocytic syndrome.

Naffaa M, Awad J, Oren I, Braun E, Lavi N.

Int J Infect Dis. 2013 Dec;17(12):e1237-9. doi: 10.1016/j.ijid.2013.05.004. Epub 2013 Jun 28.

27.

Impact of carbapenem resistance on the outcome of patients' hospital-acquired bacteraemia caused by Klebsiella pneumoniae.

Hussein K, Raz-Pasteur A, Finkelstein R, Neuberger A, Shachor-Meyouhas Y, Oren I, Kassis I.

J Hosp Infect. 2013 Apr;83(4):307-13. doi: 10.1016/j.jhin.2012.10.012. Epub 2013 Jan 10.

PMID:
23313086
28.

Prolonged fever and splinter hemorrhages in an immunocompetent traveler with disseminated histoplasmosis.

Bitterman R, Oren I, Geffen Y, Sprecher H, Schwartz E, Neuberger A.

J Travel Med. 2013 Jan-Feb;20(1):57-9. doi: 10.1111/jtm.12000.

29.

New rising infection: human herpesvirus 6 is frequent in myeloma patients undergoing autologous stem cell transplantation after induction therapy with bortezomib.

Horowitz N, Oren I, Lavi N, Zuckerman T, Benyamini N, Kra-Oz Z, Held V, Avivi I.

Bone Marrow Res. 2012;2012:409765. doi: 10.1155/2012/409765. Epub 2012 Nov 29.

30.

Reply 1.

Neuberger A, Hardak E, Oren I.

Respirology. 2013 Jan;18(1):192-3. doi: 10.1111/resp.12003. No abstract available.

PMID:
23121636
31.

Distribution of fluconazole-resistant Candida bloodstream isolates among hospitals and inpatient services in Israel.

Ben-Ami R, Rahav G, Elinav H, Kassis I, Shalit I, Gottesman T, Megged O, Weinberger M, Ciobotaro P, Shitrit P, Weber G, Paz A, Miron D, Oren I, Bishara J, Block C, Keller N, Kontoyiannis DP, Giladi M; Israeli Candidaemia Study Group.

Clin Microbiol Infect. 2013 Aug;19(8):752-6. doi: 10.1111/1469-0691.12004. Epub 2012 Sep 25.

32.

Incidence and risk factors for endocarditis among patients with health care-associated Staphylococcus aureus bacteraemia.

Finkelstein R, Agmon Y, Braun E, Kassis I, Sprecher H, Raz A, Mogilewski I, Nakhoul F, Mashiach T, Reisner S, Oren I.

Scand J Infect Dis. 2012 Dec;44(12):934-40. doi: 10.3109/00365548.2012.707331. Epub 2012 Sep 21.

PMID:
22998444
33.

Oscillatory dynamics in the hippocampus support dentate gyrus–CA3 coupling.

Akam T, Oren I, Mantoan L, Ferenczi E, Kullmann DM.

Nat Neurosci. 2012 May;15(5):763-8. doi: 10.1038/nn.3081.

34.

Outcome of Pneumocystis jirovecii pneumonia diagnosed by polymerase chain reaction in patients without human immunodeficiency virus infection.

Hardak E, Neuberger A, Yigla M, Berger G, Finkelstein R, Sprecher H, Oren I.

Respirology. 2012 May;17(4):681-6. doi: 10.1111/j.1440-1843.2012.02158.x.

PMID:
22390188
35.

Mapping out hippocampal inhibition.

Oren I, Kullmann DM.

Nat Neurosci. 2012 Feb 24;15(3):346-7. doi: 10.1038/nn.3056.

PMID:
22362104
36.

Antibiotic exposure as a risk factor for fluconazole-resistant Candida bloodstream infection.

Ben-Ami R, Olshtain-Pops K, Krieger M, Oren I, Bishara J, Dan M, Wiener-Well Y, Weinberger M, Zimhony O, Chowers M, Weber G, Potasman I, Chazan B, Kassis I, Shalit I, Block C, Keller N, Kontoyiannis DP, Giladi M; Israeli Candidemia Study Group.

Antimicrob Agents Chemother. 2012 May;56(5):2518-23. doi: 10.1128/AAC.05947-11. Epub 2012 Feb 6.

37.

The increased risk for pneumocystis pneumonia in patients receiving rituximab-CHOP-14 can be prevented by the administration of trimethoprim/sulfamethoxazole: a single-center experience.

Hardak E, Oren I, Dann EJ, Yigla M, Faibish T, Rowe JM, Avivi I.

Acta Haematol. 2012;127(2):110-4. doi: 10.1159/000334113. Epub 2011 Dec 16.

PMID:
22178955
38.

Clinical spectrum and outcome of Nocardia infection: experience of 15-year period from a single tertiary medical center.

Hardak E, Yigla M, Berger G, Sprecher H, Oren I.

Am J Med Sci. 2012 Apr;343(4):286-90. doi: 10.1097/MAJ.0b013e31822cb5dc.

PMID:
21825961
39.

Soft tissue infections caused by marine bacterial pathogens: epidemiology, diagnosis, and management.

Finkelstein R, Oren I.

Curr Infect Dis Rep. 2011 Oct;13(5):470-7. doi: 10.1007/s11908-011-0199-3.

PMID:
21785929
40.

Fatal Kaposi sarcoma after allogeneic stem cell transplant.

Avivi I, Fineman R, Haddad N, Katz T, Oren I, Rowe JM, Zuckerman T.

Leuk Lymphoma. 2011 Dec;52(12):2402-4. doi: 10.3109/10428194.2011.593275. Epub 2011 Jul 12. No abstract available.

PMID:
21749186
41.

Lack of intra-laboratory reproducibility in using Platelia Aspergillus enzyme immunoassay test for detection of Aspergillus galactomannan antigen.

Oren I, Avidor I, Sprecher H.

Transpl Infect Dis. 2012 Feb;14(1):107-9. doi: 10.1111/j.1399-3062.2011.00663.x. Epub 2011 Jul 6. No abstract available.

PMID:
21733049
42.

Polymerase chain reaction-based detection of Pneumocystis jirovecii in bronchoalveolar lavage fluid for the diagnosis of pneumocystis pneumonia.

Oren I, Hardak E, Finkelstein R, Yigla M, Sprecher H.

Am J Med Sci. 2011 Sep;342(3):182-5. doi: 10.1097/MAJ.0b013e318210ff42.

PMID:
21642823
43.

SCT in patients with carbapenem resistant Klebsiella pneumoniae: a single center experience with oral gentamicin for the eradication of carrier state.

Zuckerman T, Benyamini N, Sprecher H, Fineman R, Finkelstein R, Rowe JM, Oren I.

Bone Marrow Transplant. 2011 Sep;46(9):1226-30. doi: 10.1038/bmt.2010.279. Epub 2010 Nov 8.

PMID:
21057549
44.

Changing epidemiology of carbapenem-resistant Enterobacteriaceae carriage during an outbreak of carbapenem-resistant Klebsiella pneumoniae.

Geffen Y, Finkelstein R, Oren I, Shalaginov R, Tavleva I, Sprecher H.

J Hosp Infect. 2010 Dec;76(4):355-6. doi: 10.1016/j.jhin.2010.08.003. Epub 2010 Oct 20. No abstract available.

PMID:
20965609
45.

Currents in space: understanding inhibitory field potentials.

Oren I, Paulsen O.

J Physiol. 2010 Jun 15;588(Pt 12):2015-6. doi: 10.1113/jphysiol.2010.192443. No abstract available.

46.

Identification of the current generator underlying cholinergically induced gamma frequency field potential oscillations in the hippocampal CA3 region.

Oren I, Hájos N, Paulsen O.

J Physiol. 2010 Mar 1;588(Pt 5):785-97. doi: 10.1113/jphysiol.2009.180851. Epub 2010 Jan 5.

47.

Carbapenem resistance among Klebsiella pneumoniae isolates: risk factors, molecular characteristics, and susceptibility patterns.

Hussein K, Sprecher H, Mashiach T, Oren I, Kassis I, Finkelstein R.

Infect Control Hosp Epidemiol. 2009 Jul;30(7):666-71. doi: 10.1086/598244.

PMID:
19496647
48.

Impact of PCR-based diagnosis of invasive pulmonary aspergillosis on clinical outcome.

Hardak E, Yigla M, Avivi I, Fruchter O, Sprecher H, Oren I.

Bone Marrow Transplant. 2009 Nov;44(9):595-9. doi: 10.1038/bmt.2009.65. Epub 2009 Mar 23.

PMID:
19308034
49.

Radiological findings of early invasive pulmonary aspergillosis in immune-compromised patients.

Brook O, Guralnik L, Hardak E, Oren I, Sprecher H, Zuckerman T, Engel A, Yigla M.

Hematol Oncol. 2009 Jun;27(2):102-6. doi: 10.1002/hon.879.

PMID:
19294624
50.

Role of ionotropic glutamate receptors in long-term potentiation in rat hippocampal CA1 oriens-lacunosum moleculare interneurons.

Oren I, Nissen W, Kullmann DM, Somogyi P, Lamsa KP.

J Neurosci. 2009 Jan 28;29(4):939-50. doi: 10.1523/JNEUROSCI.3251-08.2009.

Supplemental Content

Support Center